Cargando…

ISYNA1: An Immunomodulatory-Related Prognostic Biomarker in Colon Adenocarcinoma and Pan-Cancer

Background: Colon adenocarcinoma (COAD) is a common digestive system tumor in the world. However, the role and function of ISYNA1 (inositol-3-phosphate synthase 1) in COAD remain unclear. We aim to explore the role of ISYNA1 in pan-cancer, especially in COAD. Methods: The expression, clinical charac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Zeming, Wan, Xiaoping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883116/ https://www.ncbi.nlm.nih.gov/pubmed/35237596 http://dx.doi.org/10.3389/fcell.2022.792564

Ejemplares similares

P4HA1, a Prognostic Biomarker that Correlates With Immune Infiltrates in Lung Adenocarcinoma and Pan-Cancer
por: Zhao, Qi, et al.
Publicado: (2021)

Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker
por: Liu, Weiwei, et al.
Publicado: (2022)

AP3S1 is a Novel Prognostic Biomarker and Correlated With an Immunosuppressive Tumor Microenvironment in Pan-Cancer
por: Wu, Gujie, et al.
Publicado: (2022)

Prognostic Implication and Oncogenic Role of PNPO in Pan-Cancer
por: Zhang, Lingyun, et al.
Publicado: (2022)

A Prognostic Pyroptosis-Related lncRNAs Risk Model Correlates With the Immune Microenvironment in Colon Adenocarcinoma
por: Xia, Fada, et al.
Publicado: (2021)

ARPC2: A Pan-Cancer Prognostic and Immunological Biomarker That Promotes Hepatocellular Carcinoma Cell Proliferation and Invasion
por: Huang, Shenglan, et al.
Publicado: (2022)

An Apoptosis-Related Gene Prognostic Index for Colon Cancer
por: Tang, Hanmin, et al.
Publicado: (2021)

Prognostic and Immunological Role of Key Genes of Ferroptosis in Pan-Cancer
por: Shi, Zhi-Zhou, et al.
Publicado: (2021)

Development of Tumor Mutation Burden-Related Prognostic Model and Novel Biomarker Identification in Stomach Adenocarcinoma
por: Fu, Min, et al.
Publicado: (2022)

Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-Cancer Analysis
por: Liu, Ting-Ting, et al.
Publicado: (2021)

Pan-cancer analysis of the angiotensin II receptor-associated protein as a prognostic and immunological gene predicting immunotherapy responses in pan-cancer
por: Hong, Kai, et al.
Publicado: (2022)

Construction of a prognostic assessment model for colon cancer patients based on immune-related genes and exploration of related immune characteristics
por: Wan, Yanhua, et al.
Publicado: (2022)

N6-Methylandenosine-Related lncRNA Signature Is a Novel Biomarkers of Prognosis and Immune Response in Colon Adenocarcinoma Patients
por: Zhang, Peiling, et al.
Publicado: (2021)

Identification and verification of a prognostic signature based on a miRNA–mRNA interaction pattern in colon adenocarcinoma
por: Zhao, Qiwu, et al.
Publicado: (2023)

Identification of Pan-Cancer Biomarkers Based on the Gene Expression Profiles of Cancer Cell Lines
por: Ding, ShiJian, et al.
Publicado: (2021)

Multi-Omics Analysis of MCM2 as a Promising Biomarker in Pan-Cancer
por: Yuan, Jing, et al.
Publicado: (2022)

Identify the Prognostic and Immune Profile of VSIR in the Tumor Microenvironment: A Pan-Cancer Analysis
por: Liu, Yuanyuan, et al.
Publicado: (2022)

The LIM Protein AJUBA is a Potential Oncogenic Target and Prognostic Marker in Human Cancer via Pan-Cancer Analysis
por: Song, Na, et al.
Publicado: (2022)

Pan-Cancer Methylated Dysregulation of Long Non-coding RNAs Reveals Epigenetic Biomarkers
por: Zhao, Ning, et al.
Publicado: (2022)

Construction and Validation of a Cell Cycle-Related Robust Prognostic Signature in Colon Cancer
por: Zhang, Zhiyuan, et al.
Publicado: (2020)

Fibroblast Activation Protein-Alpha is a Prognostic Biomarker Associated With Ferroptosis in Stomach Adenocarcinoma
por: Lyu, Zejian, et al.
Publicado: (2022)

Pan-cancer and single-cell analysis reveal the prognostic value and immune response of NQO1
por: Shen, Liping, et al.
Publicado: (2023)

PTBPs: An immunomodulatory-related prognostic biomarker in pan-cancer
por: Chen, Chen, et al.
Publicado: (2022)

ALKBH1-8 and FTO: Potential Therapeutic Targets and Prognostic Biomarkers in Lung Adenocarcinoma Pathogenesis
por: Wu, Geting, et al.
Publicado: (2021)

N6-Methyladenosine-Regulated mRNAs: Potential Prognostic Biomarkers for Patients With Lung Adenocarcinoma
por: Sun, Junjun, et al.
Publicado: (2021)

Hypoxia Constructing the Prognostic Model of Colorectal Adenocarcinoma and Related to the Immune Microenvironment
por: Zhang, Yuanyuan, et al.
Publicado: (2021)

Identification of Claudin-6 as a Molecular Biomarker in Pan-Cancer Through Multiple Omics Integrative Analysis
por: Zhang, Chiyuan, et al.
Publicado: (2021)

Differential Expression of the TLR4 Gene in Pan-Cancer and Its Related Mechanism
por: Hu, Jialing, et al.
Publicado: (2021)

Identification of Ferroptosis-Related Genes Signature Predicting the Efficiency of Invasion and Metastasis Ability in Colon Adenocarcinoma
por: Shi, Chunlei, et al.
Publicado: (2022)

Prognostic Signature for Lung Adenocarcinoma Patients Based on Cell-Cycle-Related Genes
por: Jiang, Wei, et al.
Publicado: (2021)

Development and Validation of a Robust Ferroptosis-Related Prognostic Signature in Lung Adenocarcinoma
por: Zhang, Anran, et al.
Publicado: (2021)

Ferroptosis-Related IncRNAs Are Prognostic Biomarker of Overall Survival in Pancreatic Cancer Patients
por: Chen, Dongjie, et al.
Publicado: (2022)

Identification of Angiogenesis-Related Prognostic Biomarkers Associated With Immune Cell Infiltration in Breast Cancer
por: Tao, Dan, et al.
Publicado: (2022)

Genome Instability and Long Noncoding RNA Reveal Biomarkers for Immunotherapy and Prognosis and Novel Competing Endogenous RNA Mechanism in Colon Adenocarcinoma
por: Ren, Ziyuan, et al.
Publicado: (2021)

Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma
por: Li, Yue, et al.
Publicado: (2021)

The Biological Function Delineated Across Pan-Cancer Levels Through lncRNA-Based Prognostic Risk Assessment Factors for Pancreatic Cancer
por: Tang, Xudong, et al.
Publicado: (2021)

Pan-Cancer Study on Protein Kinase C Family as a Potential Biomarker for the Tumors Immune Landscape and the Response to Immunotherapy
por: Abdelatty, Alaa, et al.
Publicado: (2022)

A Novel Immune-Related Prognostic Model for Response to Immunotherapy and Survival in Patients With Lung Adenocarcinoma
por: Zheng, Yujia, et al.
Publicado: (2021)

Prognostic Value of Genomic Instability of m(6)A-Related lncRNAs in Lung Adenocarcinoma
por: Li, Rui, et al.
Publicado: (2022)

SUMOylation Regulator-Related Molecules Can Be Used as Prognostic Biomarkers for Glioblastoma
por: Li, Xiaozhi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nqehrc5om1n4e28ta7noa0a2qd